Smooth muscle cell phenotypic switch: Implications for foam cell formation

Current Opinion in Lipidology

Volumn 25, Issue 5, 2014, Pages 374-379

  Chaabane, Chiraz ^a   Coen, Matteo ^a   Bochaton Piallat, Marie Luce ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

Calmodulin; Foam cells; S100A4; Smooth muscle cells; smooth muscle actin

Indexed keywords

CALMODULIN; CALVASCULIN; CHOLESTEROL; CYTOSKELETON PROTEIN; LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN;

ARTERY INTIMA PROLIFERATION; ATHEROSCLEROTIC PLAQUE; FOAM CELL; HUMAN; MACROPHAGE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SMOOTH MUSCLE FIBER; ATHEROSCLEROSIS; INTIMA; METABOLISM; PATHOLOGY; VASCULAR ENDOTHELIUM;

ATHEROSCLEROSIS; ENDOTHELIUM, VASCULAR; FOAM CELLS; HUMANS; LIPOPROTEINS, LDL; MACROPHAGES; MYOCYTES, SMOOTH MUSCLE; PHENOTYPE; PLAQUE, ATHEROSCLEROTIC; TUNICA INTIMA;

EID: 84921434332     PISSN: 09579672     EISSN: 14736535     Source Type: Journal    
DOI: 10.1097/MOL.0000000000000113     Document Type: Review

References (61)

1. Hao H, Ropraz P, Verin V, et al. Heterogeneity of smooth muscle cell populations cultured from pig coronary artery. Arterioscler Thromb Vasc Biol 2002; 22: 1093-1099.
2. Hao H, Gabbiani G, Bochaton-Piallat ML. Arterial smooth muscle cell heterogeneity: Implications for atherosclerosis and restenosis development. Arterioscler Thromb Vasc Biol 2003; 23: 1510-1520.
3. Coen M, Marchetti G, Palagi PM, et al. Calmodulin expression distinguishes the smooth muscle cell population of human carotid plaque. Am J Pathol 2013; 183: 996-1009.
4. Owens GK, Kumar MS, Wamhoff BR. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev 2004; 84: 767-801.
5. Brisset AC, Hao H, Camenzind E, et al. Intimal smooth muscle cells of porcine and human coronary artery express S100A4, a marker of the rhomboid phenotype in vitro. Circ Res 2007; 100: 1055-1062.
6. Koga J, Aikawa M. Crosstalk between macrophages and smooth muscle cells in atherosclerotic vascular diseases. Vascul Pharmacol 2012; 57: 24-28.
7. Allahverdian S, Chehroudi AC, McManus BM, et al. Contribution of intimal smooth muscle cells to cholesterol accumulation and macrophage-like cells in human atherosclerosis. Circulation 2014; 129: 1551-1559.
8. Allahverdian S, Francis GA. Cholesterol homeostasis and high-density lipoprotein formation in arterial smooth muscle cells. Trends Cardiovasc Med 2010; 20: 96-102.
9. Pirillo A, Norata GD, Catapano AL. LOX-1, OxLDL, and atherosclerosis. Mediators of inflamm 2013; 2013: Article ID 152786.
10. Levitan I, Volkov S, Subbaiah PV. Oxidized LDL: Diversity, patterns of recognition, and pathophysiology. Antioxid Redox Signal 2010; 13: 39-75.
11. Pidkovka NA, Cherepanova OA, Yoshida T, et al. Oxidized phospholipids induce phenotypic switching of vascular smooth muscle cells in vivo and in vitro. Circ Res 2007; 101: 792-801.
12. Allahverdian S, Pannu PS, Francis GA. Contribution of monocyte-derived macrophages and smooth muscle cells to arterial foam cell formation. Cardiovasc Res 2012; 95: 165-172.
13. Andreeva ER, Pugach IM, Orekhov AN. Subendothelial smooth muscle cells of human aorta express macrophage antigen in situ and in vitro. Atherosclerosis 1997; 135: 19-27.
14. Gordon D, Schwartz SM. Replication of arterial smooth muscle cells in hypertension and atherosclerosis. Am J Cardiol 1987; 59: 44A-48A.
15. Gomez D, Owens GK. Smooth muscle cell phenotypic switching in atherosclerosis. Cardiovasc Res 2012; 95: 156-164.
16. Ross R. Atherosclerosis is an inflammatory disease. Am Heart J 1999; 138: S419-S420.
17. Virmani R, Kolodgie FD, Burke AP, et al. Lessons from sudden coronary death: A comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2000; 20: 1262-1275.
18. Campbell GR, Campbell JH. The phenotypes of smooth muscle expressed in human atheroma. Ann NY Acad Sci 1990; 598: 143-158.
19. Thyberg J, Blomgren K, Hedin U, Dryjski M. Phenotypic modulation of smooth muscle cells during the formation of neointimal thickenings in the rat carotid artery after balloon injury: An electron-microscopic and stereological study. Cell Tissue Res 1995; 281: 421-433.
20. Benditt EP, Benditt JM. Evidence for a monoclonal origin of human atherosclerotic plaques. Proc Natl Acad Sci USA 1973; 70: 1753-1756.
21. Schwartz SM, Murry CE. Proliferation and the monoclonal origins of atherosclerotic lesions. Ann Rev Med 1998; 49: 437-460.
22. Murry CE, Gipaya CT, Bartosek T, et al. Monoclonality of smooth muscle cells in human atherosclerosis. Am J Pathol 1997; 151: 697-705.
23. Li S, Fan YS, Chow LH, et al. Innate diversity of adult human arterial smooth muscle cells: Cloning of distinct subtypes from the internal thoracic artery. Circ Res 2001; 89: 517-525.
24. Walker LN, Bowen-Pope DF, Ross R, Reidy MA. Production of plateletderived growth factor-like molecules by cultured arterial smooth muscle cells accompanies proliferation after arterial injury. Proc Natl Acad Sci USA 1986; 83: 7311-7315.
25. Yan Z, Hansson GK. Overexpression of inducible nitric oxide synthase by neointimal smooth muscle cells. Circ Res 1998; 82: 21-29.
26. Bochaton-Piallat ML, Ropraz P, Gabbiani F, Gabbiani G. Phenotypic heterogeneity of rat arterial smooth muscle cell clones. Implications for the development of experimental intimal thickening. Arterioscler Thromb Vasc Biol 1996; 16: 815-820.
27. Stenmark KR, Frid MG. Smooth muscle cell heterogeneity: Role of specific smoothmuscle cell subpopulations in pulmonary vascular disease.Chest1998; 114: 82S-90S.
28. Sartore S, Franch R, Roelofs M, Chiavegato A. Molecular and cellular phenotypes and their regulation in smooth muscle. Rev Physiol Biochem Pharmacol 1999; 134: 235-320.
29. RensenSS, Doevendans PA, van Eys GJ. Regulation and characteristics of vascularsmoothmusclecellphenotypic diversity.NethHeart J2007;15: 100-108.
30. Chaabane C, Otsuka F, Virmani R, Bochaton-Piallat ML. Biological responses in stented arteries. Cardiovasc Res 2013; 99: 353-363.
31. Rensen SS, Niessen PM, van Deursen JM, et al. Smoothelin-B deficiency results in reduced arterial contractility, hypertension, and cardiac hypertrophy in mice. Circulation 2008; 118: 828-836.
32. Marenholz I, Heizmann CW, Fritz G. S100 proteins in mouse and man: From evolution to function and pathology (including an update of the nomenclature). Biochem Biophys Res Commun 2004; 322: 1111-1122.
33. Sherbet GV. Metastasis promoter S100A4 is a potentially valuable molecular target for cancer therapy. Cancer Lett 2009; 280: 15-30.
34. Mishra SK, Siddique HR, Saleem M. S100A4 calcium-binding protein is key player in tumor progression and metastasis: Preclinical and clinical evidence. Cancer Metastasis Rev 2012; 31: 163-172.
35. Helfman DM, Kim EJ, Lukanidin E, Grigorian M. The metastasis associated protein S100A4: Role in tumour progression and metastasis. Br J Cancer 2005; 92: 1955-1958.
36. Bjornland K, Winberg JO, Odegaard OT, et al. S100A4 involvement in metastasis: Deregulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in osteosarcoma cells transfected with an anti- S100A4 ribozyme. Cancer Res 1999; 59: 4702-4708.
37. Mathisen B, Lindstad RI, Hansen J, et al. S100A4 regulates membrane induced activation of matrix metalloproteinase-2 in osteosarcoma cells. Clin Exp Metastasis 2003; 20: 701-711.
38. Lawrie A, Spiekerkoetter E, Martinez EC, et al. Interdependent serotonin transporter and receptor pathways regulate S100A4/Mts1, a gene associated with pulmonary vascular disease. Circ Res 2005; 97: 227-235.
39. Spiekerkoetter E, Guignabert C, de Jesus Perez V, et al. S100A4 and bone morphogenetic protein-2 codependently induce vascular smooth muscle cell migration via phospho-extracellular signal-regulated kinase and chloride intracellular channel 4. Circ Res 2009; 105: 639-647.
40. Frid MG, Li M, Gnanasekharan M, et al. Sustained hypoxia leads to the emergence of cells with enhanced growth, migratory, and promitogenic potentials within the distal pulmonary artery wall. Am J Physiol Lung Cell Mol Physiol 2009; 297: L1059-L1072.
41. O'Day DH. CaMBOT: Profiling and characterizing calmodulin-binding proteins. Cell Signal 2003; 15: 347-354.
42. Chin D, Means AR. Calmodulin: A prototypical calcium sensor. Trends Cell Biol 2000; 10: 322-328.
43. Thyberg J, Fredholm BB. Modulation of arterial smooth muscle cells from contractile to synthetic phenotype requires induction of ornithine decarboxylase activity and polyamine synthesis. Exp Cell Res 1987; 170: 153-159.
44. Tomita M, Hirata Y, Takata S, Fujita T. Effects of calcium-antagonists and calmodulin inhibitors on DNA synthesis in cultured rat vascular smooth muscle cells. Endocrinol Jpn 1987; 34: 313-318.
45. Choi J, Chiang A, Taulier N, et al. A calmodulin-binding site on cyclin E mediates Ca2+-sensitive G1/s transitions in vascular smooth muscle cells. Circ Res 2006; 98: 1273-1281.
46. Hui S, Choi J, Zaidi S, et al. Peptide-mediated disruption of calmodulin-cyclin E interactions inhibits proliferation of vascular smooth muscle cells and neointima formation. Circ Res 2011; 108: 1053-1062.
47. Ehler E, Jat PS, Noble MD, et al. Vascular smooth muscle cells of H-2KbtsA58 transgenic mice. Characterization of cell lines with distinct properties. Circulation 1995; 92: 3289-3296.
48. Adams LD, Lemire JM, Schwartz SM. A systematic analysis of 40 random genes in cultured vascular smooth muscle subtypes reveals a heterogeneity of gene expression and identifies the tight junction gene zonula occludens 2 as a marker of epithelioid "pup" smooth muscle cells and a participant in carotid neointimal formation. Arterioscler Thromb Vasc Biol 1999; 19: 2600-2608.
49. Jahn L, Kreuzer J, von Hodenberg E, et al. Cytokeratins 8 and 18 in smooth muscle cells. Detection in human coronary artery, peripheral vascular, and vein graft disease and in transplantation-associated arteriosclerosis. Arterioscler Thromb 1993; 13: 1631-1639.
50. Giachelli CM, Speer MY, Li X, et al. Regulation of vascular calcification: Roles of phosphate and osteopontin. Circ Res 2005; 96: 717-722.
51. Haefliger JA, Nicod P, Meda P. Contribution of connexins to the function of the vascular wall. Cardiovasc Res 2004; 62: 345-356.
52. Chadjichristos CE, Kwak BR. Connexins: New genes in atherosclerosis. Ann Med 2007; 39: 402-411.
53. Chadjichristos CE, Morel S, Derouette JP, et al. Targeting connexin 43 prevents platelet-derived growth factor-BB-induced phenotypic change in porcine coronary artery smooth muscle cells. Circ Res 2008; 102: 653-660.
54. Doran AC, Meller N, McNamara CA. Role of smooth muscle cells in the initiation and early progression of atherosclerosis. Arterioscler Thromb Vasc Biol 2008; 28: 812-819.
55. Stary HC, Chandler AB, Glagov S, et al. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Arterioscler Thromb 1994; 14: 840-856.
56. Choi HY, Rahmani M, Wong BW, et al. ATP-binding cassette transporter A1 expression and apolipoprotein A-I binding are impaired in intima-type arterial smooth muscle cells. Circulation 2009; 119: 3223-3231.
57. Maiolino G, Rossitto G, Caielli P, et al. The role of oxidized low-density lipoproteins in atherosclerosis: The myths and the facts. Mediators Inflamm 2013; 2013: 714653.
58. Rong JX, Shapiro M, Trogan E, Fisher EA. Transdifferentiation of mouse aortic smooth muscle cells to a macrophage-like state after cholesterol loading. Proc Natl Acad Sci USA 2003; 100: 13531-13536.
59. Yu J, Li Y, Li M, et al. Oxidized low density lipoprotein-induced transdifferentiation of bone marrow-derived smooth muscle-like cells into foam-like cells in vitro. Int J Exp Pathol 2010; 91: 24-33.
60. Murase T, Kume N, Korenaga R, et al. Fluid shear stress transcriptionally induces lectin-like oxidized LDL receptor-1 in vascular endothelial cells. Circ Res 1998; 83: 328-333.
61. Lubrano V, Balzan S. LOX-1, a new marker of risk and prognosis in coronary artery disease? Mol Cell Biochem 2013; 383: 223-230.